PRINCIPAL ACCOUNTING OFFICER · ACADIA PHARMACEUTICALS INC · Common Stock
Side
SELL
Value
$97K
Shares
4,084
Price
$23.69
Executed
Nov 18, 2025
Disclosed
Nov 19, 2025
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Nov 18 executedNov 19, 2025 disclosed
ACAD · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Kihara James filed this Form 4 reporting a open-market sale of ACAD on Nov 18, 2025. It became public on Nov 19, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
PRINCIPAL ACCOUNTING OFFICER
Kihara Jamescik:0001816160
Issuer
ACADIA PHARMACEUTICALS INCcik:0001070494
Revision history · 0
No field has changed since this record was first ingested.
